New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
17:33 EDTTKPYY, SCMPSucampo, Takeda say that Amitiza NDA will not be filed in second half of 2014
Sucampo Pharma Americas, a wholly owned subsidiary of Sucampo Pharmaceuticals (SCMP), and its development and commercialization partner's subsidiary Takeda Pharmaceuticals (TKPYY) announced that the New Drug Application, NDA, for the liquid formulation of Amitiza will not be filed in the second half of 2014. In preliminary pre-NDA meeting comments, the FDA informed Sucampo that it would require additional data to characterize pharmacokinetics of the new formulation. As a result of this outcome in conjunction with the FDA feedback, Sucampo and Takeda are now assessing next steps, which may include formulation modification.
News For SCMP;TKPYY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:52 EDTTKPYYInforma Business Information to hold a conference
Subscribe for More Information
November 18, 2014
07:37 EDTSCMPStifel to hold a conference
Subscribe for More Information
November 12, 2014
17:33 EDTSCMP, TKPYYSucampo files patent infringement suit against Dr. Reddy's Labs
Subscribe for More Information
November 11, 2014
08:01 EDTTKPYYGE Healthcare, Takeda enter into alliance agreement for R&D in hepatic fibrosis
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use